Adverse events

Arshad MS, Jamil A, Greene SJ, Van Spall HGC, Fonarow GC, Butler J, Khan MS. In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute[...]

Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin[...]

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Martin GM, Rawnsley NN, Goehring EL Jr, Jacobson AA. Brodalumab: 5-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb).[...]

Heist RS, Sands J, Bardia A, Shimizu T, Lisberg A, Krop I, Yamamoto N, Kogawa T, Al-Hashimi S, Fung SSM, Galor A, Pisetzky F, Basak[...]

Russ-Jara AL, Elkhadragy N, Arthur KJ, DiIulio JB, Militello LG, Ifeachor AP, Glassman PA, Zillich AJ, Weiner M. Cognitive task analysis of clinicians' drug-drug interaction[...]

Berthelsen DB, Simon LS, Ioannidis JPA, Voshaar M, Richards P, Goel N, Strand V, Nielsen SM, Shea BJ, Tugwell P, Bartlett SJ, Hazlewood GS, March[...]

Kulkarni AV, Tevethia H, Kumar K, Premkumar M, Muttaiah MD, Hiraoka A, Hatanaka T, Tada T, Kumada T, Kakizaki S, Vogel A, Finn RS, Rao[...]

Schwarzman LS, Ishaaya EC, Patel D, Megowan N, Thomas JL. Characteristic adverse events with intra-aortic balloon pumps: An analysis of the U.S. Food and Drug[...]

Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Böhm M, Greene SJ, Felker GM, Vaduganathan M, Butler J. Medication-Attributable Adverse Events in Heart Failure Trials.[...]

Fabrizi F, Cerutti R, Dixit V, Ridruejo E. Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis. Nefrologia[...]